EU_Haem_contents.qxp 10/3/08 16:07 Page 2
Contents
Advisory Panel
4
Foreword
5
Hal E Broxmeyer
Vice President, American Society of Hematology (ASH)
Coagulation Disorders
Haemophilia
Recent Developments in Immune Tolerance Induction in Haemophilia A 6
Wolfhart Kreuz and Carmen Escuriola Ettingshausen
Centre of Paediatrics III, Department of Haematology and Oncology and Haemostaseology,
Johann Wolfgang Goethe University Hospital, Frankfurt
Risk of Inhibitor Development in Children with Haemophilia A 8
Marijke van den Berg
Board of Directors, Meander Medical Centre, Amersfoort
Treatment of Haemophilia A with Recombinant
Antihaemophilic Factor VIII Products 11
Robert Klamroth
Director, Haemophilia Treatment Centre, Vivantes Hospital, Berlin
von Willebrand Disease
Importance of Pharmacokinetics in the Treatment of
von Willebrand Disease 16
Craig Kessler
Professor, Department of Medicine and Pathology, Georgetown University Medical Center, Washington
Platelet Disorders
Diagnosis and Management of Inherited Platelet Disorders 18
Paquita Nurden and Alan Nurden
French National Reference Centre for Inherited Platelet Diseases
Platelet Refractoriness 21
Paolo Rebulla
Director, Centre of Transfusion Medicine, Cellular Therapy and Cryobiology, Ospedale Maggiore Policlinico,
Mangiagalli Regina Elena Foundation, Milan
When Should Congenital Inherited Thrombocytopenia Be Suspected? 23
JF Viallard and P Nurden
French National Reference Centre for Inherited Platelet Diseases
First-line Idiopathic Thrombocytopenic Purpura Therapies –
Benefits and Limitations 25
Francesco Rodeghiero and Marco Ruggeri
Department of Haematology, San Bortolo Hospital, Vicenza
Haematological Malignancies
Serum Free Light Chain Assays – Their Role in Multiple Myeloma 27
Robert A Kyle
Professor of Medicine and Laboratory Medicine, Mayo Medical School, Rochester
Review of the Response Criteria for Myelodysplastic Syndrome 30
Anthony P Conley, William Stevenson and Guillermo Garcia-Manero
Leukemia Department, University of Texas MD Anderson Cancer Center
2 © TOUCH BRIEFINGS 2007
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66